As per Future Market Insights’ latest industry analysis, the valuation for the global Clinical Next-Generation Sequencing (NGS) Data Analysis Market was around US$ 2.3 Billion in 2022, and the market is projected to exhibit growth at a CAGR of 17.4% over the forecast period, with an estimated valuation of around US$ 13.1 Billion by 2033. …
Category Archives: Healthcare Trends
Buttock Augmentation Market: Aesthetic Aspirations Soar, Targeting a US$ 26.9 Billion Valuation by 2032
The buttock augmentation market had global sales of US$ 1.9 billion in 2021, according to Future Market Insights’ analysis report on the subject. By 2032, the market is anticipated to have grown at a CAGR of 27.4%, valued at US$26.9 billion. The highest revenue-generating segment is anticipated to be buttock implants, with a CAGR of …
Rising Prevalence of Periodontal Disease and Superior Precision Drive Global Prophy Dental Handpiece Market to reach US$ 398.8 million by the year 2033 | FMI
By the end of 2023, the global Prophy Dental Handpiece Market is anticipated to have a value of US$ 229.3 million, and it will grow at a CAGR of 5.7% to reach US$ 398.8 million by the year 2033. Electric-driven prophy dental handpieces are anticipated to hold the majority of the market in 2023, with …
Increased Prevalence and Awareness of Mental Health Issues Boosting Growth of Generalized Anxiety Disorder Treatment Market growing at a CAGR of 9% by 2033: FMI Study
The generalized anxiety disorder treatment market is projected to reach a market size of US$ 1800 million in 2023 and US$ 4261.25 million by 2033, growing at a CAGR of 9% over that time. The market for treating generalised anxiety disorder is expanding due to the rising incidence of mental health issues and the wide …
Growing Awareness of Importance of Oral Health Drives Salivary Gland Infection Treatment Market is expected to value of US$ 12,300 Million by 2033 | FMI Study
The Salivary Gland Infection Treatment Market is anticipated to reach a market size of US$ 5054.79 million in 2023 and US$ 12,300 million by 2033, with a CAGR of 9.3%. The rising incidence of salivary gland infections and the accessibility of pharmaceuticals to treat the condition are both factors contributing to the growth of the …
Global Sandhoff Disease Therapeutics Market to yield US$ 17.91 Million in Value as of 2033; expanding at a 6% CAGR: FMI Report
According to a recent study published by Future Market Insights, the sandhoff disease therapeutics market is slated to experience noteworthy expansion. The market for Sandhoff disease therapeutics is forecast to accumulate a market value of US$ 10 million by 2023-end, and will ultimately reach a valuation of US$ 17.91 million by 2033. According to the …
Brain Tumor Drugs Market To Surge To US$ 6.30 Billion By 2033, Driven By Steady Growth | FMI
The market for pharmaceuticals used to treat brain tumours is known as the ” Brain Tumor Drugs Market,” and it is a subset of the pharmaceutical business. Brain tumours are abnormal cell growths in the brain that may or may not be cancerous (benign) or malignant (cancerous). They can have a variety of symptoms and …
Rising Demand for Effective and Innovative Low-Grade Glioma Therapeutics Market to Reach US$ 1515.47 Million by 2033 | FMI
The global low-grade glioma therapeutics market is expected to grow from US$ 1038 Million in 2023 to US$ 1515.47 Million by 2033, at a CAGR of 4.57% during the forecast period. The growth of the market is attributed to the increasing prevalence of low-grade glioma and the rising demand for effective and innovative treatments. Low-grade …
Future Insights: Regenerative Medicine Market Poised for Impressive US$ 85.3 Billion Valuation by 2032 with 23.9% CAGR
The global Regenerative Medicine Market is on the brink of remarkable growth, with a projected surge of 23.9%, propelling it to nearly US$ 9.9 billion by the conclusion of 2022. Furthermore, it is anticipated to achieve an impressive valuation of US$ 85.3 billion by 2032. In a retrospective analysis recently conducted by Future Market Insights, …
Antidiabetics Market on the Fast Track: FMI Forecasts US$ 223 Billion Valuation by 2032 with 9.6% CAGR
In 2022, the global Antidiabetics Market is on track to achieve a valuation of US$ 89.2 billion, surging from the previous year’s figure of US$ 80.4 billion, reflecting a remarkable year-on-year growth rate of 10.9%. Looking ahead, the industry is poised to reach a substantial US$ 223 billion by 2032, marked by a robust Compound …